\nFDA (Food and Drug Administration) a aprobat versiunea de pilul\u0103 a medicamentului anti-obezitate Wegovy de la Novo Nordisk, oferind companiei daneze un avantaj competitiv important pe pia\u0163a tratamentelor pentru pierderea \u00een greutate. Noua formul\u0103 zilnic\u0103 vine dup\u0103 ani de cercet\u0103ri \u015fi ar putea fi mai atractiv\u0103 pentru pacien\u0163ii care evit\u0103 injec\u0163iile, scrie Financial Times.<\/p>\n
\nNovo Nordisk a anun\u0163at c\u0103 produce deja pilulele \u015fi se a\u015fteapt\u0103 la o lansare oficial\u0103 \u00een ianuarie 2026. Rivalul Eli Lilly se preg\u0103te\u015fte \u015fi el pentru aprobare, cu versiunea pilul\u0103 a medicamentului Zepbound, dup\u0103 ce a raportat rezultate clinice pozitive \u00een studiile recente.<\/p>\n
\nPilula Wegovy, care con\u0163ine substan\u0163a activ\u0103 semaglutid, a demonstrat o pierdere medie \u00een greutate de 17% la 64 de s\u0103pt\u0103m\u00e2ni, comparativ cu reducerea de 20,2% raportat\u0103 de pilula Eli Lilly la 72 de s\u0103pt\u0103m\u00e2ni. Pre\u0163ul pilulei Novo Nordisk va fi de 149 dolari pe lun\u0103, mai accesibil dec\u00e2t pilula Eli Lilly, care va costa 346 dolari prin platforma TrumpRx.<\/p>\n
\nAcest pas marcheaz\u0103 o schimbare semnificativ\u0103 \u00een pia\u0163a global\u0103 a tratamentelor anti-obezitate, care p\u00e2n\u0103 acum a fost dominat\u0103 de injec\u0163ii. Analistii consider\u0103 c\u0103 aprobarea pilulei va ajuta Novo Nordisk s\u0103 rec\u00e2\u015ftige cot\u0103 de pia\u0163\u0103, \u00een timp ce consumatorii au acum o alternativ\u0103 mai convenabil\u0103 \u015fi poten\u0163ial mai atractiv\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"
FDA (Food and Drug Administration) a aprobat versiunea de pilul\u0103 a medicamentului anti-obezitate Wegovy de la Novo Nordisk, oferind companiei daneze un avantaj competitiv important pe pia\u0163a tratamentelor pentru pierderea \u00een greutate. Noua formul\u0103 zilnic\u0103 vine dup\u0103 ani de cercet\u0103ri \u015fi ar putea fi mai atractiv\u0103 pentru pacien\u0163ii care evit\u0103 injec\u0163iile, scrie Financial Times. Novo […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[293,47,323,16559,60,37919],"class_list":["post-243557","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-intrare","tag-lansare","tag-medicamente","tag-obezitate","tag-piata","tag-pilula"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/243557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=243557"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/243557\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=243557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=243557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=243557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}